1652.HK Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 09:38):
Our systems believe the stock currently is undervalued by 0.10% compare to its pairs and should correct upwards.

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China...

Stats
Tagesvolumen	235 000
Durchschnittsvolumen	159 271
Marktkapitalisierung	722.68M
EPS	HKD-0.0352 ( Q4 \| 2023-12-31 )
Last Dividend	HKD0.00420 ( 2022-06-07 )
Next Dividend	HKD0 ( N/A )
P/E	-19.40 (Sector) 0 (Industry) 0
ATR14	HKD0.0300 (3.09%)

0013.HK -0.72%

0239.HK 1.24%

0455.HK 1.96%

0512.HK -0.21%

0570.HK 0.83%

0719.HK 0.75%

0858.HK 2.56%

0867.HK 0.76%

0874.HK 0.24%

0911.HK -1.75%

1011.HK -10.26%

1312.HK 3.03%

1349.HK 0.56%

1498.HK 0.00%

1513.HK 0.78%

1558.HK 5.15%

1652.HK -2.02%

1681.HK 2.58%

2161.HK 5.00%

2196.HK 0.46%

2552.HK 2.70%

2633.HK 1.56%

2877.HK -1.79%

3737.HK 0.00%

6185.HK 0.72%

6896.HK -0.65%

8049.HK -0.76%

8329.HK 3.62%

8622.HK 0.00%

9989.HK 2.52%

Korrelation (AI algo v.1.1b): Undervalued: 0.10% HKD0.971 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

Fusen Pharmaceutical Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Fusen Pharmaceutical Finanzdaten

Annual	2023
Umsatz:	HKD565.61M
Bruttogewinn:	HKD299.51M (52.95 %)
EPS:	HKD-0.0500

FY	2023
Umsatz:	HKD565.61M
Bruttogewinn:	HKD299.51M (52.95 %)
EPS:	HKD-0.0500

FY	2022
Umsatz:	HKD491.76M
Bruttogewinn:	HKD225.02M (45.76 %)
EPS:	HKD-0.0458

FY	2021
Umsatz:	HKD385.66M
Bruttogewinn:	HKD211.13M (54.75 %)
EPS:	HKD0.0210

Financial Reports:

No articles found.

Fusen Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Fusen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.527 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	HKD0.00620	2018-09-13
Last Dividend	HKD0.00420	2022-06-07
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	HKD0.0436	--
Avg. Dividend % Per Year	0.00%	--
Score	1.08	--
Div. Sustainability Score	1.527
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-08-30)

HKD0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.08

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
07 Jun 2022	HKD0.00420	30 Nov -0001	30 Nov -0001	30 Nov -0001
17 Sep 2021	HKD0.00680	30 Nov -0001	30 Nov -0001	30 Nov -0001
08 Jun 2021	HKD0.00540	30 Nov -0001	30 Nov -0001	30 Nov -0001
15 Sep 2020	HKD0.00510	30 Nov -0001	30 Nov -0001	30 Nov -0001
03 Jul 2020	HKD0.00400	31 Mar 2020	06 Jul 2020	10 Aug 2020
13 Sep 2019	HKD0.00330	30 Aug 2019	16 Sep 2019	29 Nov 2019
03 Jul 2019	HKD0.00860	29 Mar 2019	04 Jul 2019	09 Aug 2019
13 Sep 2018	HKD0.00620	31 Aug 2018	14 Sep 2018	30 Nov 2018

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1373.HK	Ex Dividend Knight	2023-10-04	Semi-Annually	0.00%
0006.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
3968.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
0921.HK	Ex Dividend Knight	2023-07-10	Sporadic	0.00%
2199.HK	Ex Dividend Junior	2023-09-18	Annually	0.00%
0518.HK	Ex Dividend Junior	2023-09-01	Sporadic	0.00%
1709.HK	Ex Dividend Junior	2023-09-13	Annually	0.00%
0103.HK	Ex Dividend Junior	2023-07-14	Sporadic	0.00%
8092.HK	Ex Dividend Junior	2023-08-14	Sporadic	0.00%
1171.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0641	1.500	-1.283	-1.924	[0 - 0.5]
returnOnAssetsTTM	-0.0270	1.200	-0.900	-1.080	[0 - 0.3]
returnOnEquityTTM	-0.0612	1.500	-1.791	-2.69	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.853	0.800	-0.735	-0.588	[1 - 3]
quickRatioTTM	0.329	0.800	-2.77	-2.22	[0.8 - 2.5]
cashRatioTTM	0.0524	1.500	-0.820	-1.230	[0.2 - 2]
debtRatioTTM	0.256	-1.500	5.73	-8.60	[0 - 0.6]
interestCoverageTTM	6.34	1.000	8.76	8.76	[3 - 30]
operatingCashFlowPerShareTTM	-0.0979	2.00	-0.0326	-0.0653	[0 - 30]
freeCashFlowPerShareTTM	-0.186	2.00	-0.0931	-0.186	[0 - 20]
debtEquityRatioTTM	0.611	-1.500	7.56	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.530	1.000	4.51	4.51	[0.2 - 0.8]
operatingProfitMarginTTM	0.0379	1.000	-1.241	-1.241	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.213	1.000	-2.30	-2.30	[0.2 - 2]
assetTurnoverTTM	0.421	0.800	-0.527	-0.422	[0.5 - 2]
Total Score				1.527

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-18.63	1.000	-1.983	0	[1 - 100]
returnOnEquityTTM	-0.0612	2.50	-1.151	-2.69	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.186	2.00	-0.0621	-0.186	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0979	2.00	-0.0326	-0.0653	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.943	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.130	1.000	-5.74	0	[0.1 - 0.5]
Total Score				-2.08

Fusen Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fusen Pharmaceutical

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.